EVALUATION OF CITALOPRAM AFFECTED THE GENERALIZED ANXIETY DISORDER PARTICIPANTS’ QUALITY OF LIFE. Int. Res. J. Pharm. 2023, 14 (11), 21-25. https://doi.org/10.56802/kedfgd52.